239 related articles for article (PubMed ID: 11050100)
21. Up-regulation of liver uncoupling protein-2 mRNA by either fish oil feeding or fibrate administration in mice.
Tsuboyama-Kasaoka N; Takahashi M; Kim H; Ezaki O
Biochem Biophys Res Commun; 1999 Apr; 257(3):879-85. PubMed ID: 10208878
[TBL] [Abstract][Full Text] [Related]
22. Effects of dietary fats and cholesterol on liver lipid content and hepatic apolipoprotein A-I, B, and E and LDL receptor mRNA levels in cebus monkeys.
Hennessy LK; Osada J; Ordovas JM; Nicolosi RJ; Stucchi AF; Brousseau ME; Schaefer EJ
J Lipid Res; 1992 Mar; 33(3):351-60. PubMed ID: 1314879
[TBL] [Abstract][Full Text] [Related]
23. Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver.
Roglans N; Bellido A; Rodríguez C; Cabrero A; Novell F; Ros E; Zambón D; Laguna JC
Clin Pharmacol Ther; 2002 Dec; 72(6):692-701. PubMed ID: 12496750
[TBL] [Abstract][Full Text] [Related]
24. Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice.
Weinstock PH; Bisgaier CL; Hayek T; Aalto-Setala K; Sehayek E; Wu L; Sheiffele P; Merkel M; Essenburg AD; Breslow JL
J Lipid Res; 1997 Sep; 38(9):1782-94. PubMed ID: 9323588
[TBL] [Abstract][Full Text] [Related]
25. Elevated hepatic apolipoprotein A-I transcription is associated with diet-induced hyperalphalipoproteinemia in rabbits.
Schwab DA; Rea TJ; Hanselman JC; Bisgaier CL; Krause BR; Pape ME
Life Sci; 2000 Mar; 66(18):1683-94. PubMed ID: 10809165
[TBL] [Abstract][Full Text] [Related]
26. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Princen HM; Kooistra T
Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
[TBL] [Abstract][Full Text] [Related]
27. Mechanism for peroxisome proliferator-activated receptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes.
Nakatani T; Tsuboyama-Kasaoka N; Takahashi M; Miura S; Ezaki O
J Biol Chem; 2002 Mar; 277(11):9562-9. PubMed ID: 11782473
[TBL] [Abstract][Full Text] [Related]
28. NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha.
Morishima A; Ohkubo N; Maeda N; Miki T; Mitsuda N
J Biol Chem; 2003 Oct; 278(40):38188-93. PubMed ID: 12882972
[TBL] [Abstract][Full Text] [Related]
29. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
30. Response of ApoA-IV in pigs to long-term increased dietary oil intake and to the degree of unsaturation of the fatty acids.
Navarro MA; Acín S; Carnicer R; Guzmán-García MA; Arbonés-Mainar JM; Surra JC; Cebrián JA; Arnal C; Isabel B; López-Bote CJ; Osada J
Br J Nutr; 2004 Nov; 92(5):763-9. PubMed ID: 15533264
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of action of fibrates on lipid and lipoprotein metabolism.
Staels B; Dallongeville J; Auwerx J; Schoonjans K; Leitersdorf E; Fruchart JC
Circulation; 1998 Nov; 98(19):2088-93. PubMed ID: 9808609
[TBL] [Abstract][Full Text] [Related]
32. RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo.
Mukherjee R; Strasser J; Jow L; Hoener P; Paterniti JR; Heyman RA
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):272-6. PubMed ID: 9484993
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
[TBL] [Abstract][Full Text] [Related]
34. Effect of beta-3 adrenoceptor stimulation on the levels of ApoA-I, PPARα, and PPARγ in apolipoprotein E-deficient mice.
Shi ST; Li YF; Guo YQ; Wang ZH
J Cardiovasc Pharmacol; 2014 Nov; 64(5):407-11. PubMed ID: 24979391
[TBL] [Abstract][Full Text] [Related]
35. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
Srivastava RA; Srivastava N; Averna M
Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
[TBL] [Abstract][Full Text] [Related]
36. Lack of triglyceride-lowering properties of fish oil in apolipoprotein e-deficient mice.
Asset G; Baugé E; Fruchart JC; Dallongeville J
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):401-6. PubMed ID: 11231920
[TBL] [Abstract][Full Text] [Related]
37. Administration of a PPARalpha agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio.
Schultze AE; Alborn WE; Newton RK; Konrad RJ
J Lipid Res; 2005 Aug; 46(8):1591-5. PubMed ID: 15897610
[TBL] [Abstract][Full Text] [Related]
38. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
Hughes TA; Stentz F; Gettys T; Smith SR
Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916
[TBL] [Abstract][Full Text] [Related]
39. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.
Vu-Dac N; Schoonjans K; Laine B; Fruchart JC; Auwerx J; Staels B
J Biol Chem; 1994 Dec; 269(49):31012-8. PubMed ID: 7983038
[TBL] [Abstract][Full Text] [Related]
40. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.
Schoonjans K; Staels B; Auwerx J
J Lipid Res; 1996 May; 37(5):907-25. PubMed ID: 8725145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
